US-based biopharmaceutical company Kadmon Holdings (Kadmon) has announced a public offering of common stock shares to raise up to $40m in total.

The company plans to use the funds towards clinical development of its product candidates and general corporate purposes.

Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares.

"Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares."

The US-based specialist pharmaceutical company plans to use the funds for general corporate purposes.

SK Capital has announced plans to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company, for $110m.

SK Capital is a private investment firm based in the US, while Perrigo is an Irish healthcare company. The transaction will complement the existing businesses of SK Capital.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now